Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.

1. An open-label, randomised study was performed to assess the effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin. 2. Fourteen healthy male volunteers received either a single oral dose of 120 mg tenidap sodium or matching placebo capsules from days 11 to 36. A single oral dose of 0.75 mg kg-1 warfarin was administered on days 1 and 32. 3. The mean prothrombin AUC(1,120h) value between baseline and day 32 increased from 1692.4 +/- 234.5 s h to 1769.3 +/- 218.0 s h in the group given tenidap, and decreased from 1747.6 +/- 289.4 s h to 1708.1 +/- 236.8 s h in the placebo group. 4. Tenidap caused a slight delay in the normalisation of prothrombin times following the second dose of warfarin on day 32 compared with the first dose on day 1. This was significant at 36, 48, 72 and 96 h but not at 120 h after administration of warfarin. 5. The mean percentage of unbound warfarin in the tenidap group (0.08% +/- 0.09) was significantly different (P = 0.047) from that in the placebo group (-0.03% +/- 0.10) but this was not considered to be clinically meaningful. 6. These data indicate that prothrombin times should be monitored during concomitant administration of tenidap and warfarin.

[1]  M. Joannidis,et al.  Management of venous thromboembolism. , 1997, The New England journal of medicine.

[2]  M. Gardner,et al.  Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers. , 1995, British journal of clinical pharmacology.

[3]  W. Lore.  Transient ischaemic attacks and strokes: overview , 1994 .

[4]  R. Ward,et al.  Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. , 1992, British journal of rheumatology.

[5]  J. Sipe,et al.  Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. , 1992, Journal of immunology.

[6]  S. Connolly,et al.  Stroke prevention in nonvalvular atrial fibrillation. , 1991, Annals of internal medicine.

[7]  R. Verbeeck.  Pharmacokinetic Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs , 1990, Clinical pharmacokinetics.

[8]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[9]  P. Stein,et al.  Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. , 1989, Chest.

[10]  S. Schulman,et al.  Interaction of ibuprofen and warfarin on primary haemostasis. , 1989, British journal of rheumatology.

[11]  Furst De.  Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications. , 1988 .

[12]  V. Hachinski,et al.  Transient ischemic attacks and stroke. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[13]  D. Furst.  Clinically important interactions of nonsteroidal antiinflammatory drugs with other medications. , 1988, The Journal of rheumatology. Supplement.

[14]  J. Greist,et al.  Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs. , 1986, The American journal of medicine.

[15]  D. Brater.  Drug-drug and drug-disease interactions with nonsteroidal anti-inflammatory drugs. , 1986, The American journal of medicine.

[16]  G. Longenecker,et al.  Kinetics of ibuprofen effect on platelet and endothelial prostanoid release , 1985, Clinical pharmacology and therapeutics.

[17]  R. Day,et al.  Anti-rheumatic drug interactions. , 1984, Clinics in rheumatic diseases.

[18]  P. Beaune,et al.  Human hepatic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[19]  B. Stricker,et al.  Interactions between flurbiprofen and coumarins. , 1982, British medical journal.

[20]  D. Triplett,et al.  Procedures for the coagulation laboratory , 1981 .

[21]  R. Philp,et al.  Effect of ibuprofen on platelet function in normal subjects and hemophiliac patients , 1978, Clinical pharmacology and therapeutics.

[22]  J. Slattery,et al.  Effect of ibuprofen on protein binding of warfarin in human serum. , 1977, Journal of pharmaceutical sciences.

[23]  M. Walter,et al.  Interaction study between phenprocoumon and flurbiprofen. , 1977, Current medical research and opinion.